Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,810 JPY | +0.14% | -1.54% | 0.00% |
May. 06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
May. 06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- MarketScreener Strategies